CAT Inhibitors

5-Azacytidine can induce hypomethylation of DNA, potentially leading to the downregulation of CAT gene expression by altering the transcriptional activity of genes involved in the oxidative stress response.

By inhibiting histone deacetylases, Trichostatin A promotes acetylation of histone proteins, which may result in the reduced transcription of the CAT gene due to changes in chromatin accessibility at the CAT gene locus.

Methotrexate disrupts folate metabolism, which is crucial for the synthesis of S-adenosylmethionine, a key methyl donor for DNA methylation; this disruption may lead to decreased expression of CAT by altering methylation patterns within its promoter region.

Lead(II) acetate exposure can induce oxidative stress, which may downregulate the expression of antioxidant genes, including CAT, due to lead-mediated interference with transcription factors and DNA-binding proteins.

Arsenic trioxide can interfere with cellular signaling pathways, such as those involving the transcription factor Nrf2, which is essential for the induction of CAT expression; this interference may result in the decreased expression of CAT.

Hydroquinone, through its metabolism, can generate reactive oxygen species that can deplete cellular antioxidant defenses and lead to the decreased expression of CAT as part of the cellular response to increased oxidative burden.

Acrylamide′s metabolites can form adducts with DNA, potentially resulting in the downregulation of CAT expression by causing mutations or epigenetic alterations that disrupt the normal transcription of the CAT gene.

Benzene metabolites, known to be genotoxic, can damage bone marrow cells, potentially leading to the reduced expression of CAT by causing chromosomal aberrations or epigenetic modifications that suppress the CAT gene′s transcriptional activity.